Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Evaluation of Schistocyte Analysis By a Novel Automated Digital Cell Morphology Application

Anne-Sophie Hervent, Maaike Godefroid, Barbara Cauwelier, PhD, Achiel Van Hoof, Johan Billiet, MD, Jan Emmerechts

Blood (2014) 124 (21): 4878.

https://doi.org/10.1182/blood.V124.21.4878.4878

Published: 2014

Journal Articles

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

Carla AL Assaf, Els Lierman, PhD, Florence Van Obbergh, MD, Timothy Devos, MD PhD, Johan Billiet, MD, Carlos Graux, MD PhD, Lucienne Michaux, MD PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD PhD

Blood (2014) 124 (21): 5584.

https://doi.org/10.1182/blood.V124.21.5584.5584

Published: 2014

Journal Articles

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Carlos Graux, MD, PhD, Johan Billiet, MD, Peter Vandenberghe, MD, PhD

Blood (2013) 122 (21): 5258.

https://doi.org/10.1182/blood.V122.21.5258.5258

Published: 2013

Journal Articles

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Johan Billiet, MD, Carlos Graux, MD, PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD, PhD

Blood (2013) 122 (21): 5264.

https://doi.org/10.1182/blood.V122.21.5264.5264

Published: 2013

Journal Articles

Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/ PCM1-JAK2 –positive chronic eosinophilic leukemia

Els Lierman, Dominik Selleslag, Sanne Smits, Johan Billiet, Peter Vandenberghe

Blood (2012) 120 (7): 1529–1531.

https://doi.org/10.1182/blood-2012-06-433821

Published: 2012

Journal Articles

The JAK2 V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation

Kristien Van Pelt, Friedel Nollet, Dominik Selleslag, Laurent Knoops, Stefan N. Constantinescu, Arnold Criel, Johan Billiet

Blood (2008) 112 (3): 921–922.

https://doi.org/10.1182/blood-2008-04-154708

Published: 2008

Journal Articles

Results of Haploidentical Stem Cell Transplantation after a Conditioning Regimen without Total Body Irradiation in Elderly Patients with Advanced Myeloid and Lymphoid Malignancies.

Dominik L.D. Selleslag, MD, Melanny Hidajat, M.D., Jan Van Droogenbroeck, M.D., Achiel Van Hoof, M.D., Johan Billiet, M.D, Dimitri Dehenau, Ph., Friedel Nollet, Ph.D., Arnold Criel, M.D., Ph.D.

Blood (2007) 110 (11): 3074.

https://doi.org/10.1182/blood.V110.11.3074.3074

Published: 2007

Journal Articles

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Norbert Gattermann, Johan Billiet, Ralf Kronenwett, Esther Zipperer, Ulrich Germing, Friedel Nollet, Arnold Criel, Dominik Selleslag

Blood (2007) 109 (3): 1334–1335.

https://doi.org/10.1182/blood-2006-05-022491

Published: 2007

Journal Articles

Killer Immunoglobulin-Like Receptors (KIRs) Genotypes in a Belgian Population.

Melanny Hidajat, MD, Dominik Selleslag, MD, Achiel Van Hoof, MD, Jan Van Droogenbroeck, MD, Johan Billiet, MD, Arnold Criel, MD

Blood (2004) 104 (11): 3852.

https://doi.org/10.1182/blood.V104.11.3852.3852

Published: 2004

Journal Articles

Diagnostic Utility of PRV-1 mRNA Quantification in Polycythemia Vera and Essential Thrombocythemia.

Johan Billiet, MD, Sofie Tilleman, Jan Van Droogenbroeck, MD, Friedel Nollet, PhD, Dominik Selleslag, MD, Kurt Geldhof, MD, Melanny Hidajat, MD, Achiel Van Hoof, MD, Arnold Criel, MD PhD

Blood (2004) 104 (11): 4751.

https://doi.org/10.1182/blood.V104.11.4751.4751

Published: 2004

Journal Articles

Efficacy of Donor Lymphocyte Infusions in Myelodysplastic Syndromes Relapsing after Allogeneic Stem Cell Transplantation: Importance of Karyotype.

Dominik L.D. Selleslag, M.D., Friedel Nollet, Ph.D., Johan Billiet, M.D., Jan Van Droogenbroeck, M.D., Achiel Van Hoof, M.D., Koen Van Eygen, M.D., Melanny Hidajat, M.D., Arnold Criel, M.D.

Blood (2004) 104 (11): 1450.

https://doi.org/10.1182/blood.V104.11.1450.1450

Published: 2004

Journal Articles

Do B-cell chronic lymphocytic leukemia patients with Ig V H 3-21 genes constitute a new subset of chronic lymphocytic leukemia?

Friedel Nollet, Barbara Cauwelier, Johan Billiet, Dominik Selleslag, Achiel Van Hoof, Andries Louwagie, Arnold Criel

Blood (2002) 100 (3): 1097–1099.

https://doi.org/10.1182/blood-2002-03-0867

Published: 2002

NARROW

Evaluation of Schistocyte Analysis By a Novel Automated Digital Cell Morphology Application

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/ PCM1-JAK2 –positive chronic eosinophilic leukemia

The JAK2 V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation

Results of Haploidentical Stem Cell Transplantation after a Conditioning Regimen without Total Body Irradiation in Elderly Patients with Advanced Myeloid and Lymphoid Malignancies.

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Killer Immunoglobulin-Like Receptors (KIRs) Genotypes in a Belgian Population.

Diagnostic Utility of PRV-1 mRNA Quantification in Polycythemia Vera and Essential Thrombocythemia.

Efficacy of Donor Lymphocyte Infusions in Myelodysplastic Syndromes Relapsing after Allogeneic Stem Cell Transplantation: Importance of Karyotype.

Do B-cell chronic lymphocytic leukemia patients with Ig V H 3-21 genes constitute a new subset of chronic lymphocytic leukemia?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only